• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Jay Edelberg - Articles and news items

Sanofi and Regeneron report positive top-line results with alirocumab from first Phase 3 study of a PCSK9 inhibitor for LDL cholesterol reduction

Industry news / 16 October 2013 / Sanofi

Alirocumab monotherapy reduced “bad” cholesterol three times more than ezetimibe…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +